{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:30:54Z","timestamp":1787617854003,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T00:00:00Z","timestamp":1354665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1245\/s10434-012-2768-6","type":"journal-article","created":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T18:15:06Z","timestamp":1354644906000},"page":"1694-1700","source":"Crossref","is-referenced-by-count":12,"title":["Does Histologic Type Correlate to Outcome after Pelvic Exenteration for Cervical and Vaginal Cancer?"],"prefix":"10.1245","volume":"20","author":[{"given":"Glauco","family":"Baiocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Cardoso","family":"Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Chaves","family":"Faloppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian Yuri","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato Almeida Rosa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dirlei","family":"Begnami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Augusto","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ademar","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,5]]},"reference":[{"key":"2768_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin."},{"key":"2768_CR2","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(00)04646-8","volume":"357","author":"P Sasieni","year":"2001","unstructured":"Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet. 2001;357:1490\u20133.","journal-title":"Lancet."},{"key":"2768_CR3","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1158\/1055-9965.EPI-05-0231","volume":"14","author":"F Bray","year":"2005","unstructured":"Bray F, Carstensen B, M\u00f8ller H, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomark Prev. 2005;14:2191\u20139.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"2768_CR4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1525-1438.1999.09895.x","volume":"9","author":"CH Lai","year":"1999","unstructured":"Lai CH, Hsueh S, Hong JH, et al. Are adenocarcinomas and adenosquamous carcinomas different from squamous carcinomas in stage IB and II cervical cancer patients undergoing primary radical surgery? Int J Gynecol Cancer. 1999;9:28\u201336.","journal-title":"Int J Gynecol Cancer."},{"key":"2768_CR5","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1097-0142(19900601)65:11<2507::AID-CNCR2820651120>3.0.CO;2-9","volume":"65","author":"PJ Eifel","year":"1990","unstructured":"Eifel PJ, Morris M, Oswald MJ, Wharton JT, Delclos L. Adenocarcinoma of the uterine cervix: prognosis and patterns of failure in 367 cases. Cancer. 1990;65:2507\u201314.","journal-title":"Cancer."},{"key":"2768_CR6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/cncr.20877","volume":"103","author":"ME Sherman","year":"2005","unstructured":"Sherman ME, Wang SS, Carreon J, Devesa SS. Mortality trends for cervical squamous and adenocarcinoma in the United States. Cancer. 2005;103:1258\u201364.","journal-title":"Cancer."},{"key":"2768_CR7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.2000.5826","volume":"78","author":"HO Smith","year":"2000","unstructured":"Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: a 24-year population-based study. Gynecol Oncol. 2000;78:97\u2013105.","journal-title":"Gynecol Oncol."},{"key":"2768_CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","volume":"98","author":"X Castellsagu\u00e9","year":"2006","unstructured":"Castellsagu\u00e9 X, D\u00edaz M, De Sanjos\u00e9 S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006;98:303\u201315.","journal-title":"J Natl Cancer Inst."},{"key":"2768_CR9","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cncr.20064","volume":"100","author":"SS Wang","year":"2004","unstructured":"Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976\u20132000. Cancer. 2004;100:1035\u201344.","journal-title":"Cancer."},{"key":"2768_CR10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2009.09.040","volume":"116","author":"LT Gien","year":"2010","unstructured":"Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: a unique cervical cancer. Gynecol Oncol. 2010;116:140\u20136.","journal-title":"Gynecol Oncol."},{"key":"2768_CR11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","volume":"350","author":"F Landoni","year":"1997","unstructured":"Landoni F, Maneo A, Colombo A, et al. Randomized study of radical surgery versus radiotherapy for stage Ib\u2013IIa cervical cancer. Lancet. 1997;350:535\u201340.","journal-title":"Lancet."},{"key":"2768_CR12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","volume":"340","author":"M Morris","year":"1999","unstructured":"Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137\u201343.","journal-title":"N Engl J Med."},{"key":"2768_CR13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","volume":"73","author":"A Sedlis","year":"1999","unstructured":"Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage 1b carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol. 1999;73:177\u201383.","journal-title":"Gynecol Oncol."},{"key":"2768_CR14","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","volume":"340","author":"HM Keys","year":"1999","unstructured":"Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154\u201361.","journal-title":"N Engl J Med."},{"key":"2768_CR15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","volume":"340","author":"PG Rose","year":"1999","unstructured":"Rose PG, Bundy BN, Watkins J, et al. Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144\u201353.","journal-title":"N Engl J Med."},{"key":"2768_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.2000.6010","volume":"80","author":"F Landoni","year":"2001","unstructured":"Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3\u201312.","journal-title":"Gynecol Oncol."},{"key":"2768_CR17","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","volume":"18","author":"WA Peters","year":"2000","unstructured":"Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix. J Clin Oncol. 2000;18:1606\u201313.","journal-title":"J Clin Oncol."},{"key":"2768_CR18","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","volume":"22","author":"PJ Eifel","year":"2004","unstructured":"Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22:872\u201380.","journal-title":"J Clin Oncol."},{"key":"2768_CR19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ygyno.2004.11.007","volume":"96","author":"BJ Monk","year":"2005","unstructured":"Monk BJ, Wang J, Im S, et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical\u2013pathologic analysis of a Gynecologic Oncology Group\/Southwest Oncology Group\/Radiation Therapy Oncology Group trial. Gynecol Oncol. 2005;96:721\u20138.","journal-title":"Gynecol Oncol."},{"key":"2768_CR20","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","volume":"26","author":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration","year":"2008","unstructured":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26:5802\u201312.","journal-title":"J Clin Oncol."},{"key":"2768_CR21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1470-2045(06)70903-2","volume":"7","author":"M H\u00f6ckel","year":"2006","unstructured":"H\u00f6ckel M, Dornh\u00f6fer N. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol. 2006;7:837\u201347.","journal-title":"Lancet Oncol."},{"key":"2768_CR22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO;2-A","volume":"1","author":"A Brunschwig","year":"1948","unstructured":"Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. Cancer. 1948;1:177\u201383.","journal-title":"Cancer."},{"key":"2768_CR23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0090-8258(89)90512-X","volume":"33","author":"RA Lawhead","year":"1989","unstructured":"Lawhead RA, Clark DG, Smith DH, Pierce VK, Lewis JL Jr. Pelvic exenteration for recurrent or persistent gynaecologic malignancies: a 10- year review of the Memorial-Sloan-Kettering Cancer Center experience (1972\u20131981). Gynecol Oncol. 1989;33:279\u201382.","journal-title":"Gynecol Oncol."},{"key":"2768_CR24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/gyno.1996.4532","volume":"64","author":"JF Magrina","year":"1997","unstructured":"Magrina JF, Stanhope CR, Waever AL. Pelvic exenterations: supralevator, infralevator, and with vulvectomy. Gynecol Oncol. 1997;64:130\u20135.","journal-title":"Gynecol Oncol."},{"key":"2768_CR25","first-page":"934","volume":"74","author":"GW Morley","year":"1989","unstructured":"Morley GW, Hopkins MP, Lindenauer SM, Roberts JA. Pelvic exenteration, university of Michigan: 100 patients at 5\u00a0years. Obstet Gynecol. 1989;74:934\u201343.","journal-title":"Obstet Gynecol."},{"key":"2768_CR26","first-page":"1027","volume":"73","author":"HM Shingleton","year":"1989","unstructured":"Shingleton HM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM Jr. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol. 1989;73:1027\u201334.","journal-title":"Obstet Gynecol."},{"key":"2768_CR27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0002-9378(75)90908-4","volume":"121","author":"RE Symmonds","year":"1975","unstructured":"Symmonds RE, Pratt JH, Webb MJ. Exenterative operations: experience with 198 patients. Am J Obstet Gynecol. 1975;121:907\u201318.","journal-title":"Am J Obstet Gynecol."},{"key":"2768_CR28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0002-9378(77)90521-X","volume":"129","author":"F Rutledge","year":"1977","unstructured":"Rutledge F, Smith J, Wharton J, O\u2019Quinn AG. Pelvic exenteration; analysis of 296 patients. Am J Obstet Gynecol. 1977;129:881\u201392.","journal-title":"Am J Obstet Gynecol."},{"key":"2768_CR29","first-page":"617","volume":"69","author":"W Roberts","year":"1987","unstructured":"Roberts W, Cavanagh D, Bryson P, Lyman GH, Hewitt S. Major morbidity after pelvic exenteration: a seven year experience. Obstet Gynecol. 1987;69:617\u201321.","journal-title":"Obstet Gynecol."},{"key":"2768_CR30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0090-8258(90)90092-Y","volume":"38","author":"KD Hatch","year":"1990","unstructured":"Hatch KD, Gelder MS, Soong SJ, Baker VV, Shingleton HM. Pelvic exenteration with low rectal anastomosis: survival, complications, and prognostic factors. Gynecol Oncol. 1990;38:462\u20137.","journal-title":"Gynecol Oncol."},{"key":"2768_CR31","first-page":"773","volume":"79","author":"C Matthews","year":"1992","unstructured":"Matthews C, Morris M, Burke T, Gershenson DM, Wharton JT, Rutledge FN. Pelvic exenteration in the elderly patient. Obstet Gynecol. 1992;79:773\u20137.","journal-title":"Obstet Gynecol."},{"key":"2768_CR32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/gyno.1996.0040","volume":"60","author":"M Morris","year":"1996","unstructured":"Morris M, Alvarez RD, Kinney WK, Wilson TO. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol Oncol. 1996;60:288\u201391.","journal-title":"Gynecol Oncol."},{"key":"2768_CR33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/gyno.1993.1170","volume":"50","author":"B Miller","year":"1993","unstructured":"Miller B, Morris M, Rutledge F, et al. Aborted exenterative procedures in recurrent cervical cancer. Gynecol Oncol. 1993;50:94\u20139.","journal-title":"Gynecol Oncol."},{"key":"2768_CR34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2009.03.029","volume":"114","author":"A Maggioni","year":"2009","unstructured":"Maggioni A, Roviglione G, Landoni F, et al. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol. 2009;114:64\u20138.","journal-title":"Gynecol Oncol."},{"key":"2768_CR35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1525-1438.2005.15311.x","volume":"15","author":"S Sharma","year":"2005","unstructured":"Sharma S, Odunsi K, Driscoll D, Lele S. Pelvic exenteration for gynecological malignancies: twenty-year experience at Rosewell Park Cancer Institute. Int J Gynecol Cancer. 2005;15:475\u201382.","journal-title":"Int J Gynecol Cancer."},{"key":"2768_CR36","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1245\/ASO.2006.03.082","volume":"13","author":"TM Pawlik","year":"2005","unstructured":"Pawlik TM, Skibber JM, Miguel AR. Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol. 2005;13:612\u201323.","journal-title":"Ann Surg Oncol."},{"key":"2768_CR37","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ygyno.2003.11.003","volume":"92","author":"G Houvenaeghel","year":"2004","unstructured":"Houvenaeghel G, Moutardier V, Karsenty G, et al. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Gynecol Oncol. 2004;92:680\u20133.","journal-title":"Gynecol Oncol."},{"key":"2768_CR38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/1097-0142(197009)26:3<513::AID-CNCR2820260304>3.0.CO;2-6","volume":"26","author":"AS Ketcham","year":"1970","unstructured":"Ketcham AS, Deckers PJ, Sugarbaker EV, Hoye RC, Thomas LB, Smith RR. Pelvic exenteration for carcinoma of the uterine cervix\u2014a 15-year experience. Cancer. 1970;26:513\u201321.","journal-title":"Cancer."},{"key":"2768_CR39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0140-6736(95)91146-4","volume":"345","author":"N Saunders","year":"1995","unstructured":"Saunders N. Pelvic exenteration: by whom and for whom? Lancet. 1995;345:5\u20136.","journal-title":"Lancet."},{"key":"2768_CR40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0002-9378(85)80167-8","volume":"152","author":"CR Stanhope","year":"1985","unstructured":"Stanhope CR, Symmonds RE. Palliative exenteration\u2014what, when, and why? Am J Obstet Gynecol. 1985;152:12\u20136.","journal-title":"Am J Obstet Gynecol."},{"key":"2768_CR41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jso.20442","volume":"93","author":"GC Guimaraes","year":"2006","unstructured":"Guimaraes GC, Ferreira FO, Rossi BM, et al. Double-barreled wet colostomy is a safe option for simultaneous urinary and fecal diversion. Analysis of 56 procedures from a single institution. J Surg Oncol. 2006;93:206\u201311.","journal-title":"J Surg Oncol."},{"key":"2768_CR42","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/1097-0142(19951115)76:10+<1948::AID-CNCR2820761311>3.0.CO;2-T","volume":"76","author":"HM Shingleton","year":"1995","unstructured":"Shingleton HM, Bell MC, Fremgen A, et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer. 1995;76:1948\u201355.","journal-title":"Cancer."},{"key":"2768_CR43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0167-8140(88)90018-7","volume":"12","author":"PW Grigsby","year":"1988","unstructured":"Grigsby PW, Perez CA, Kuske RR, et al. Adenocarcinoma of the uterine cervix: lack of evidence for a poor prognosis. Radiother Oncol. 1988;12:289\u201396.","journal-title":"Radiother Oncol."},{"key":"2768_CR44","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1006\/gyno.1996.0327","volume":"63","author":"KY Look","year":"1996","unstructured":"Look KY, Brunetto VL, Clarke-Pearson DL, et al. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol. 1996;63:304\u201311.","journal-title":"Gynecol Oncol."},{"key":"2768_CR45","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1525-1438.2006.00628.x","volume":"16","author":"KBM Lee","year":"2006","unstructured":"Lee KBM, Lee JM, Park CY, Lee KB, Cho HY, Ha SY. What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case\u2013control study. Int J Gynecol Cancer. 2006;16:1569\u201373.","journal-title":"Int J Gynecol Cancer."},{"key":"2768_CR46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0090-8258(88)90281-8","volume":"31","author":"LC Kilgore","year":"1998","unstructured":"Kilgore LC, Soong SJ, Gore H, Shingleton HM, Hatch KD, Partridge EE. Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol Oncol. 1998;31:137\u201348.","journal-title":"Gynecol Oncol."},{"key":"2768_CR47","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/1097-0142(20011101)92:9<2471::AID-CNCR1597>3.0.CO;2-K","volume":"92","author":"GC Alfsen","year":"2001","unstructured":"Alfsen GC, Kristensen GB, Skovlund E, Pettersen EO, Abeler VM. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix. Cancer. 2001;92:2471\u201383.","journal-title":"Cancer."},{"key":"2768_CR48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/gyno.1995.1265","volume":"59","author":"PJ Eifel","year":"1995","unstructured":"Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage 1B cervical carcinoma. Gynecol Oncol. 1995;59:38\u201344.","journal-title":"Gynecol Oncol."},{"key":"2768_CR49","first-page":"912","volume":"77","author":"MP Hopkins","year":"1991","unstructured":"Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol. 1991;77:912\u20137.","journal-title":"Obstet Gynecol."},{"key":"2768_CR50","first-page":"46","volume":"65","author":"JS Berek","year":"1985","unstructured":"Berek JS, Hacker NS, Fu YS, Sokale JR, Leuchter RC, Lagasse LD. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival. Obstet Gynecol. 1985;65:46\u201352.","journal-title":"Obstet Gynecol."},{"key":"2768_CR51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0090-8258(89)90032-2","volume":"35","author":"W Kleine","year":"1989","unstructured":"Kleine W, Rau K, Schwoeorer D, Pfleiderer A. Prognosis of adenocarcinoma of the cervix uteri: a comparative study. Gynecol Oncol. 1989;35:145\u201359.","journal-title":"Gynecol Oncol."},{"key":"2768_CR52","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/gyno.1999.5364","volume":"73","author":"RJ Chen","year":"1999","unstructured":"Chen RJ, Lin YH, Chen CA, Huang SC, Chow SN, Hsieh CY. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol Oncol. 1999;73:184\u201390.","journal-title":"Gynecol Oncol."},{"key":"2768_CR53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0029-7844(02)02275-5","volume":"101","author":"MLJ Davy","year":"2003","unstructured":"Davy MLJ, Dodd TJ, Luke CJ, Roder DM. Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival. Obstet Gynecol. 2003;101:38\u201345.","journal-title":"Obstet Gynecol."},{"key":"2768_CR54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/gyno.2000.5935","volume":"79","author":"T Nakanishi","year":"2000","unstructured":"Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K. A comparison of prognoses of pathologic stage IB adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2000;79:289\u201393.","journal-title":"Gynecol Oncol."},{"key":"2768_CR55","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/ejso.1999.0923","volume":"26","author":"T Irie","year":"2000","unstructured":"Irie T, Kigawa J, Minagawa Y, et al. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Eur J Surg Oncol. 2000;26:464\u20137.","journal-title":"Eur J Surg Oncol."},{"key":"2768_CR56","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1034\/j.1600-0412.2002.811208.x","volume":"81","author":"N Takeda","year":"2002","unstructured":"Takeda N, Sakuragi N, Takeda M, et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand. 2002;81:1144\u201351.","journal-title":"Acta Obstet Gynecol Scand."},{"key":"2768_CR57","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2012.01.012","volume":"125","author":"V Galic","year":"2012","unstructured":"Galic V, Herzog TJ, Lewin SN, et al. Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol. 2012;125:287\u201391.","journal-title":"Gynecol Oncol."},{"key":"2768_CR58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/gyno.1995.1186","volume":"58","author":"M Crozier","year":"1995","unstructured":"Crozier M, Morris M, Levenback C, Lucas KR, Atkinson EN, Wharton JT. Pelvic exenteration for adenocarcinoma of the uterine cervix. Gynecol Oncol. 1995;58:74\u20138.","journal-title":"Gynecol Oncol."},{"key":"2768_CR59","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ygyno.2012.03.001","volume":"125","author":"AM Schmidt","year":"2012","unstructured":"Schmidt AM, Imesch P, Fink D, Egger H. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecol Oncol. 2012;125:604\u20139.","journal-title":"Gynecol Oncol."},{"key":"2768_CR60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/gyno.1999.5536","volume":"75","author":"RR Barakat","year":"1999","unstructured":"Barakat RR, Goldman NA, Patel DA, Venkatraman ES, Curtin JP. Pelvic exenteration for recurrent endometrial cancer. Gynecol Oncol. 1999;75:99\u2013102.","journal-title":"Gynecol Oncol."},{"key":"2768_CR61","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ygyno.2006.06.027","volume":"103","author":"S Marnitz","year":"2006","unstructured":"Marnitz S, K\u00f6hler C, M\u00fcller M, Behrens K, Hasenbein K, Schneider A. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol. 2006;103:1023\u201330.","journal-title":"Gynecol Oncol."},{"key":"2768_CR62","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0090-8258(87)90029-1","volume":"26","author":"FN Rutledge","year":"1987","unstructured":"Rutledge FN, McGuffee VB. Pelvic exenteration: prognostic significance of regional lymph node metastasis. Gynecol Oncol. 1987;26:347\u201380.","journal-title":"Gynecol Oncol."},{"key":"2768_CR63","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0090-8258(89)90524-6","volume":"33","author":"CW Drescher","year":"1989","unstructured":"Drescher CW, Hopkins MP, Roberts JA. Comparison of the pattern of metastatic spread of squamous cell cancer and adenocarcioma of the uterine cervix. Gynecol Oncol. 1989;33:340\u20133.","journal-title":"Gynecol Oncol."},{"key":"2768_CR64","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2012.03.010","volume":"125","author":"PG Rose","year":"2012","unstructured":"Rose PG. Are the differences in treatment outcome for adenocarcinoma of the cervix different enough to change the treatment paradigm? Gynecol Oncol. 2012;125:285\u20136.","journal-title":"Gynecol Oncol."},{"key":"2768_CR65","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jso.21518","volume":"101","author":"C Fotopoulou","year":"2010","unstructured":"Fotopoulou C, Neumann U, Kraetschell R, et al. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies. J Surg Oncol. 2010;101:507\u201312.","journal-title":"J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-012-2768-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2768-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T11:22:54Z","timestamp":1559647374000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-012-2768-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,5]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2768"],"URL":"https:\/\/doi.org\/10.1245\/s10434-012-2768-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,5]]}}}